DOI: 10.4244/EIJV10I2A44

Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation

Tina H. Leetmaa1*, MD; Steen H. Poulsen1, MD; Bjarne L. Nørgaard1, MD; Kaj-Erik Klaaborg2, MD; Kim Terp2, MD; Søren Høyer3, MD; Evald H. Christiansen1, MD; Henning R. Andersen1, MD

We report two cases of aortic valve stent thrombosis after uneventful transcatheter transapical aortic valve implantation of the 29 mm Edwards SAPIEN XT (Edwards Lifesciences, Irvine, CA, USA) in high-risk patients. Subcutaneous low molecular weight heparin 5,000 units daily for five days, aspirin 75 mg daily lifelong, and clopidogrel 75 mg daily for 12 months were given. After four weeks, antiplatelet therapy was reduced to monotherapy due to bleeding problems. Shortly after, the patients developed refractory heart failure and died on day 106 and on day 137, respectively. Transoesophageal echocardiography (Online Figure 1 and Moving image 1 and 2) and multislice computed tomography (Figure 1A and Figure 1B) showed signs of stent valve thrombosis.

The autopsy and histology showed that the valve leaflets were thickened, stiff and with fibrosis on both sides of the leaflets, which was more than three months old. Two layers of thrombosis were seen on top of the fibrosis (Figure 1C and Figure 1D). The most profound layer of thrombus was more than one month old, and the fresh thrombosis was very recent with the specific lines of Zahn. There were no signs of macro defects or endocarditis on the leaflets.

Figure 1. A) Multislice computed tomography image in case 1 showing the aortic stent prosthesis in the long-axis view in systole with thrombus (low attenuation mass, arrow) and fixation of the “right” leaflet. B) Multislice computed tomography image in case 1 showing the aortic stent prosthesis in short-axis view in systole with thrombus visualised as low attenuation masses (arrows) in relation to the “right” and “left” leaflet, respectively. C) Macroscopic image of the aortic valve stent. D) Masson trichrome stained section of a thrombosed leaflet: a) fresh thrombosis, b) recent thrombosis, c) fibrosis, d) native leaflet, and e) fibrosis.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Online Figure 1. Transoesophageal echocardiography in case 1 showing the aortic stent prosthesis in the long-axis view with an immobile “right” valve leaflet (white arrow) whereas the “non-coronary” leaflet (red arrow) is well opened in systole.

Moving image 1. Transoesophageal echocardiogram in case 2 showing the aortic stent prosthesis in the two-dimensional longitudinal axis.

Moving image 2. The three-dimensional short-axis view with a thickened and immobile “right” valve leaflet.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiogram in case 2 showing the aortic stent prosthesis in the two-dimensional longitudinal axis.

Moving image 2. The three-dimensional short-axis view with a thickened and immobile "right" valve leaflet.

Volume 10 Number 2
Jun 20, 2014
Volume 10 Number 2
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV10I11A233 Mar 20, 2015
Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis
de Brito Jr F et al
free

10.4244/EIJV7I1A28 May 17, 2011
Valve thrombosis after transcatheter heart valve implantation
Tay E et al
free

10.4244/EIJV11SWA28 Sep 17, 2015
Antithrombotic therapy in TAVI patients: changing concepts
Gargiulo G et al
free

10.4244/EIJV15I7A102 Sep 20, 2019
Antithrombotic therapy after TAVI: where are we going?
Wilkins B et al
free

10.4244/EIJV9SSA9 Sep 15, 2013
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
Collet J and Montalescot G
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA7 Sep 18, 2016
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?
Chakravarty T et al
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA8 Sep 18, 2016
Late degeneration of transcatheter aortic valves: pathogenesis and management
Barbanti M and Tamburino C
free
Trending articles
317.8

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.85

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
42.95

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved